What diagnoses can cause hemolytic anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hemolytic Anemia

Hemolytic anemia results from either hereditary disorders affecting red blood cell structure/function or acquired conditions including immune-mediated destruction, infections, and mechanical trauma.

Hereditary Causes

Red Blood Cell Enzyme Deficiencies

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme defect causing hemolysis, particularly triggered by oxidative stress from infections or certain medications 1, 2
  • Pyruvate kinase deficiency is the most frequent glycolytic pathway enzyme abnormality and the most common cause of hereditary nonspherocytic hemolytic anemia, resulting from ATP depletion in red blood cells 3
  • Other enzymopathies include pyruvate kinase deficiency and various glycolytic enzyme defects 4, 2

Red Blood Cell Membrane Disorders (Membranopathies)

  • Hereditary spherocytosis is characterized by spherocytes on peripheral smear, positive family history, and negative direct antiglobulin test 2
  • Dehydrated hereditary stomatocytosis (DHSt) has emerged as the second most frequent type of congenital hemolytic anemia since genetic diagnosis became available 5
  • These disorders cause poor red cell deformability leading to splenic sequestration and destruction 6

Hemoglobinopathies

  • Sickle cell anemia and thalassemias (particularly alpha-thalassemia in Southeast Asian populations) cause chronic hemolysis 2
  • Alpha-thalassemia in its severe form typically leads to hydrops fetalis and fetal demise 4

Acquired Causes

Immune-Mediated Hemolytic Anemia (DAT-Positive)

  • Warm autoimmune hemolytic anemia (wAIHA) is caused by IgG autoantibodies, with DAT positive for IgG, C3d, or both 7
  • Cold agglutinin disease (CAD) results from monoclonal IgM antibodies specific to the Ii blood group system, with DAT positive only for C3d 7
  • Alloimmune hemolysis from blood group incompatibility, including Rh (D, c, C, e, E), anti-Kell (K, k), anti-Duffy (Fya), and anti-Kidd (Jka, Jkb) antibodies 4
  • Drug-induced immune hemolytic anemia (DIIHA) appears similar to wAIHA with DAT showing IgG and/or C3d 7
  • Mixed AIHA has DAT positive for both IgG and C3d 7
  • Paroxysmal cold hemoglobinuria (PCH) is driven by biphasic cold-reactive IgG antibody recruiting complement, with DAT positive only for C3d 7

Infectious Causes

  • Parvovirus B19 is the most commonly reported infectious cause of fetal anemia, targeting erythroid progenitor cells and causing aplastic crisis 4
  • Malaria and babesiosis directly invade and destroy red blood cells 2
  • Other infections including toxoplasmosis, cytomegalovirus (CMV), coxsackie virus, and syphilis have been associated with hemolytic anemia in rare cases 4

Microangiopathic Hemolytic Anemia

  • Thrombotic microangiopathy (TMA) occurs when red cell membranes are damaged by microthrombi in circulation, leading to intravascular hemolysis and schistocyte formation 1, 6
  • Atypical hemolytic uremic syndrome (aHUS) involves complement-mediated thrombotic microangiopathy requiring urgent ADAMTS13 activity testing 1

Mechanical and Traumatic Causes

  • Direct mechanical trauma from prosthetic heart valves or other cardiovascular devices 6
  • Fetomaternal hemorrhage occurring as acute or chronic events 4
  • Twin anemia-polycythemia sequence in monochorionic twin pregnancies, occurring spontaneously in 3-5% or after laser therapy for twin-twin transfusion syndrome in 13% of cases 4

Other Acquired Causes

  • Oxidative stress from medications or toxins, particularly in patients with underlying enzyme deficiencies 6
  • Hypersplenism causing sequestration and premature destruction of red blood cells 8
  • Systemic diseases including malignancies and autoimmune disorders 2, 7

Diagnostic Approach

Initial Laboratory Evaluation

  • Confirm hemolysis with elevated reticulocyte count, increased LDH, decreased haptoglobin, and elevated unconjugated bilirubin 8, 1, 2
  • Peripheral blood smear to identify morphologic abnormalities: spherocytes suggest hereditary spherocytosis, schistocytes indicate microangiopathy, and relatively normal morphology with anisocytosis/poikilocytosis suggests enzyme deficiency 8

Distinguishing Immune from Non-Immune Causes

  • Direct antiglobulin test (DAT) differentiates immune-mediated (DAT-positive) from non-immune causes (DAT-negative) 6, 7
  • For DAT-negative cases with suspected hereditary disorders, proceed with red cell enzyme assays (particularly G6PD and pyruvate kinase) and consider comprehensive gene panel analysis of 68 hemolytic anemia-related genes 8, 5

Important Caveats

  • Reticulocyte count may be falsely low in hereditary hemolytic anemias before splenectomy because younger defective cells are preferentially sequestered in the spleen 8
  • Blood testing for enzyme activity should be delayed at least 50 days after transfusion to minimize interference from donor red cells 3
  • Haptoglobin is the most sensitive indicator of hemolysis, becoming reduced early in the hemolytic process 8

References

Guideline

Approach to Managing Hemolytic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hemolytic anemia.

American family physician, 2004

Guideline

Pyruvate Kinase Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Diagnosis of congenital hemolytic anemia by comprehensive gene analysis: significance and limitations].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2021

Research

Hemolytic Anemia: Evaluation and Differential Diagnosis.

American family physician, 2018

Guideline

Hereditary Hemolytic Anemia Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the typical labs and symptoms of hemolytic anemia and how is it managed?
What is the best initial treatment for a hospitalized patient who develops hemolytic anemia, characterized by severe anemia (low hemoglobin), elevated reticulocytes, low haptoglobin, and high lactate dehydrogenase (LDH), after being started on antibiotics (Abx)?
What is the diagnosis for a 10-year-old female patient presenting with pallor, splenomegaly, a total leukocyte count (TLC) of 30,000, severe anemia with a hemoglobin level of 5.6, no lymphadenopathy, elevated serum glutamic-pyruvic transaminase (SGPT) of 51, total serum bilirubin of 4.6 with unconjugated bilirubin of 3.6?
An 8-year-old girl, with a height and weight in the 10th percentile, presents with severe eye pain, scleral icterus, hepatomegaly, fever, tachycardia, and hypotension, along with laboratory findings of decreased haptoglobin and hemoglobin, what is the most likely diagnosis given her symptoms and lab results?
What is the diagnosis and management for a patient with normocytic anemia, elevated Lactate Dehydrogenase (LDH), and a high reticulocyte (retic) count?
How should I evaluate and manage a patient with elevated hemoglobin, hematocrit, and red blood cell count?
In a male patient who has undergone lateral internal sphincterotomy, fissurectomy/fistulotomy, and recent hemorrhoidectomy, what is the most likely cause of dulled urinary and defecatory urgency and what diagnostic work‑up and management should be pursued?
What is the incidence of pediatric obstructive sleep apnea?
In patients with acute coronary syndrome (including ST‑segment elevation myocardial infarction, non‑ST‑segment elevation myocardial infarction, or unstable angina), what is the recommended ticagrelor dosing, contraindications, common adverse effects, and suitable alternative antiplatelet agents?
In patients on chronic dialysis with heart failure with reduced ejection fraction, is spironolactone indicated?
What are the etiologies, clinical presentation, laboratory findings, and management strategies for primary hyperparathyroidism compared with secondary hyperparathyroidism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.